A randomised, double-blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO-524 in dogs with atopic dermatitis.
Takeo NishiyamaMasashi KusakabeIchiro ImanishiTadashi HisanoTeruyasu FukamachiNorihito TaguchiKeita IyoriYun-Hsiao HsiaoPublished in: Veterinary dermatology (2023)
The combination of PCSO-524 and oclacitinib may help to alleviate the rebound effect that occurs when tapering down the dosage of oclacitinib, as compared to using oclacitinib alone for the management of cAD.